Sanofi released aide-mémoire ahead of October 30 results
Sanofi made its aide-mémoire for Q3 2026 available ahead of its Q3 2026 results, scheduled for publication on October 30, 2026.
What happened
Sanofi announced the availability of the aide-mémoire for Q3 2026 results on the "Investors" page of sanofi.com. The document was the aide-mémoire for Q3 2026 results, a background note meant to help readers place figures in context. The announcement was issued in Paris, France – October 6, 2026.
Modelling note showed which adjustments to watch
Prepared each quarter, this document is intended to support financial modelling of the quarterly results, in other words the estimates investors make of the figures. It covers non-comparable items, foreign currency impact, and share count.
For private investors, that made the release a working aid rather than new business news. The three listed topics showed which one-off adjustments, currency effects and share figures the company itself highlighted for interpreting the quarter.
Release followed Sanofi's regular quarterly routine
According to the company, the aide-mémoire was prepared each quarter. That routine placed the Q3 2026 document ahead of the formal results publication.
Investors awaited full results on October 30
Sanofi's Q3 2026 results were scheduled for publication on October 30, 2026. The aide-mémoire for Q3 2026 results was already available on the "Investors" page of sanofi.com.
The next step for investors was therefore the scheduled results release itself. Until then, the available note offered the company's stated framework for reading those figures.
